Quick Answer
ADAPTIN BIO, INC. reported Diluted EPS of $0.03 per share (loss) for fiscal year 2024.
ADAPTIN BIO, INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2024 | -$0.03 | -88.2% |
| 2023 | -$0.02 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.20 | +41.2% | -11.1% |
| June 30, 2025 | -$0.18 | +28.0% | -80.0% |
| March 31, 2025 | -$0.10 | +0.0% | +70.6% |
| September 30, 2024 | -$0.34 | -3677.8% | -36.0% |
| June 30, 2024 | -$0.25 | -24900.0% | -150.0% |
| March 31, 2024 | -$0.10 | -9900.0% | -1011.1% |
| September 30, 2023 | -$0.01 | -800.0% | -800.0% |
| June 30, 2023 | -$0.00 | — | +0.0% |
- ADAPTIN BIO, INC. showed a decrease of -88.2% in Diluted EPS compared to the prior fiscal year.
- Over the 2023–2024 period, ADAPTIN BIO, INC.’s diluted eps has declined by 88.2% (from $0.02 per share (loss) to $0.03 per share (loss)).
- The most recent figure is from ADAPTIN BIO, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: